Business Description
Kontafarma China Holdings Ltd
NAICS : 327310
ISIN : KYG8918D1088
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.26 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.32 | |||||
Debt-to-EBITDA | -11.64 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 0.74 | |||||
Beneish M-Score | -2.65 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -7.1 | |||||
3-Year EBITDA Growth Rate | -24.1 | |||||
3-Year EPS without NRI Growth Rate | -12.6 | |||||
3-Year FCF Growth Rate | -26.3 | |||||
3-Year Book Growth Rate | -4.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 58.88 | |||||
9-Day RSI | 53.16 | |||||
14-Day RSI | 52.28 | |||||
6-1 Month Momentum % | -8.57 | |||||
12-1 Month Momentum % | -30.43 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.53 | |||||
Quick Ratio | 1.28 | |||||
Cash Ratio | 0.23 | |||||
Days Inventory | 111.57 | |||||
Days Sales Outstanding | 50.75 | |||||
Days Payable | 13.27 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 125.83 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 58.25 | |||||
Operating Margin % | -7.82 | |||||
Net Margin % | -3.57 | |||||
FCF Margin % | 1.6 | |||||
ROE % | -2.64 | |||||
ROA % | -1.52 | |||||
ROIC % | -5.51 | |||||
ROC (Joel Greenblatt) % | -4.88 | |||||
ROCE % | -1.95 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Price-to-Owner-Earnings | 18 | |||||
PS Ratio | 0.24 | |||||
PB Ratio | 0.19 | |||||
Price-to-Tangible-Book | 0.4 | |||||
Price-to-Free-Cash-Flow | 17.5 | |||||
Price-to-Operating-Cash-Flow | 5.83 | |||||
EV-to-EBIT | -15.6 | |||||
EV-to-EBITDA | -15.6 | |||||
EV-to-Revenue | 0.55 | |||||
EV-to-FCF | 33.32 | |||||
Price-to-Projected-FCF | 0.45 | |||||
Price-to-Median-PS-Value | 0.3 | |||||
Earnings Yield (Greenblatt) % | -6.41 | |||||
FCF Yield % | 6.42 | |||||
Forward Rate of Return (Yacktman) % | -42.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Kontafarma China Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 809.107 | ||
EPS (TTM) (HK$) | -0.005 | ||
Beta | 0.32 | ||
Volatility % | 34.95 | ||
14-Day RSI | 52.28 | ||
14-Day ATR (HK$) | 0.002736 | ||
20-Day SMA (HK$) | 0.036 | ||
12-1 Month Momentum % | -30.43 | ||
52-Week Range (HK$) | 0.026 - 0.045 | ||
Shares Outstanding (Mil) | 5,588.57 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kontafarma China Holdings Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kontafarma China Holdings Ltd Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Kontafarma China Holdings Ltd Frequently Asked Questions
What is Kontafarma China Holdings Ltd(HKSE:01312)'s stock price today?
When is next earnings date of Kontafarma China Holdings Ltd(HKSE:01312)?
Does Kontafarma China Holdings Ltd(HKSE:01312) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |